Literature DB >> 3169687

Conjunctival biopsy in Sjögren's syndrome: correlations between histological and immunohistochemical features.

M Raphael1, S Bellefqih, J C Piette, P Le Hoang, P Debre, G Chomette.   

Abstract

We have examined conjunctival biopsies from nine primary and two secondary cases of Sjögren's syndrome. In all cases histopathological examination revealed metaplasia of the conjunctival epithelium associated with a reduced number of goblet cells and a polymorphic inflammatory cell infiltrate of the stroma. Using monoclonal antibodies with texture analysis of stained preparations we have shown that in all cases the lymphocytic infiltrate was predominantly T-cell but with substantial numbers of IgA and IgG secretory B-cells in three cases. The number of Langerhans cells present was reduced in biopsies showing the most marked degree of epithelial metaplasia.

Entities:  

Mesh:

Year:  1988        PMID: 3169687     DOI: 10.1111/j.1365-2559.1988.tb02024.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

1.  Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.

Authors:  Cintia S De Paiva; Cindy S Hwang; John D Pitcher; Solherny B Pangelinan; Ehsan Rahimy; Wei Chen; Kyung-Chul Yoon; William J Farley; Jerry Y Niederkorn; Michael E Stern; De-Quan Li; Stephen C Pflugfelder
Journal:  Rheumatology (Oxford)       Date:  2009-12-09       Impact factor: 7.580

2.  Small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye disease.

Authors:  Shimin Li; Karina Nikulina; Jason DeVoss; Ava J Wu; Erich C Strauss; Mark S Anderson; Nancy A McNamara
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

3.  Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome.

Authors:  Kyung-Chul Yoon; Chang-Soo Park; In-Cheon You; Hwan-Jun Choi; Kwang-Hoon Lee; Seong-Kyu Im; Hong-Yong Park; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

4.  Molecular mechanism of proinflammatory cytokine-mediated squamous metaplasia in human corneal epithelial cells.

Authors:  Shimin Li; Marianne Gallup; Ying-Ting Chen; Nancy A McNamara
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

Review 5.  [Classification of ocular surface disease. Part 1].

Authors:  F E Kruse; C Cursiefen; B Seitz; H E Völcker; G O H Naumann; L Holbach
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.174

6.  NK cells promote Th-17 mediated corneal barrier disruption in dry eye.

Authors:  Xiaobo Zhang; Eugene A Volpe; Niral B Gandhi; Chris S Schaumburg; Karyn F Siemasko; Solherny B Pangelinan; Scott D Kelly; Adrian C Hayday; De-Quan Li; Michael E Stern; Jerry Y Niederkorn; Stephen C Pflugfelder; Cintia S De Paiva
Journal:  PLoS One       Date:  2012-05-08       Impact factor: 3.240

7.  CD8⁺ cells regulate the T helper-17 response in an experimental murine model of Sjögren syndrome.

Authors:  X Zhang; C S Schaumburg; T G Coursey; K F Siemasko; E A Volpe; N B Gandhi; D-Q Li; J Y Niederkorn; M E Stern; S C Pflugfelder; C S de Paiva
Journal:  Mucosal Immunol       Date:  2013-09-11       Impact factor: 7.313

Review 8.  Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.

Authors:  Terry G Coursey; Cintia S de Paiva
Journal:  Clin Ophthalmol       Date:  2014-08-04

9.  Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye.

Authors:  Ying-Ting Chen; Shimin Li; Karina Nikulina; Travis Porco; Marianne Gallup; Nancy McNamara
Journal:  Mol Vis       Date:  2009-03-23       Impact factor: 2.367

10.  Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome.

Authors:  Laura Contreras-Ruiz; Birgit Regenfuss; Fayaz Ahmad Mir; James Kearns; Sharmila Masli
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.